Our Blogs

Class Action Lawsuit Filed Over Stryker Rejuvenate Hip Implants
May 24, 2014 by Adler Markoff & Associates
A Florida man has filed a class action lawsuit against Stryker Orthopedics over its Rejuvenate hip, claiming that individuals who received the recalled hip replacement system should receive free medical monitoring to avoid suffering an adverse reaction to the device. The complaint was filed by Bernard G. Owen on January 25, in the U.S. District Court for the Southern District of Florida, and seeks class action status to represent all Florida residents who received a Stryker Rejuvenate hip implant. If you have suffered a major complication that you believe to have been caused by the Stryker Rejuvenate hip device, or another potentially defective medical device, contact our knowledgeable attorneys at AMA Law to discuss your legal options. You may have grounds to file a product liability lawsuit against the medical device company, in order to pursue financial compensation for your injuries and medical expenses.

STRYKER REJUVENATE HIP IMPLANT RECALL

The Stryker Rejuvenate modular hip stem was recalled in June 2012 amid concerns about metal blood poisoning, which could result from metal debris produced by the metal parts of the hip implant rubbing against one another. Unlike traditional hip implants, which are made up of a single femoral component, Stryker’s Rejuvenate device featured a two-part neck and stem design, which allowed surgeons to customize the length of the implant to suit individual patients. Unfortunately, while hip replacement systems are expected to last 15 to 20 years, Stryker’s hip implant was recalled only three years after it entered the market. The medical device maker recalled its Rejuvenate and ABG II modular neck hip stems, acknowledging at the time that the components were prone to fretting and corrosion, possibly causing swelling, pain and catastrophic failure of the hip device.

ADVERSE REACTIONS LINKED TO HIP DEVICE

According to allegations raised in Owen’s class action suit, the plaintiff received the hip implant in July 2011, approximately one year before it was removed from the market. Owen claims that, as a result of problems in the device’s design, he and other patients who received a Rejuvenate hip now require medical monitoring to ensure that the implant has not corroded, fretted or otherwise failed. Owen notes that this medical monitoring should include regular blood tests for elevated levels of cobalt and chromium, imaging tests to detect local adverse tissue reactions and pseudotumor formation, and any additional physical exams that may reveal reactions indicative of device failure. “As long as the Rejuvenate System hip implants remain within the body of the patient, the likely potential for future device failure exists,” claims Owen in the class action.

CONTACT OUR ATTORNEYS TO FILE A CLAIM

Since Stryker announced its decision to remove the Rejuvenate and ABG II hip implants from the market, a growing number of product liability lawsuits have been filed on behalf of patients who have had their implant fail, often resulting in the need for revision surgery to remove the device. According to this litigation, Stryker allegedly delayed recalling the defective hip and failed to issue timely warnings about the risk of early failure. If you received a Stryker hip or another hip implant that you believe to be defective, consult our reputable lawyers at AMA Law for legal help. You may be entitled to reimbursement for your faulty device-related injuries and medical bills, which you can pursue by filing a product liability lawsuit against the medical device manufacturing company. With our law firm on your side, you can hold the allegedly negligent device maker liable for its defective product, and protect yourself and your family from further harm.